312 related articles for article (PubMed ID: 14501715)
21. Clinical outcome after retroperitoneal lymphadenectomy of patients with pure testicular teratoma.
Rabbani F; Farivar-Mohseni H; Leon A; Motzer RJ; Bosl GJ; Sheinfeld J
Urology; 2003 Dec; 62(6):1092-6. PubMed ID: 14665362
[TBL] [Abstract][Full Text] [Related]
22. Adult primary pure teratoma of the testis. The Indiana experience.
Leibovitch I; Foster RS; Ulbright TM; Donohue JP
Cancer; 1995 May; 75(9):2244-50. PubMed ID: 7712432
[TBL] [Abstract][Full Text] [Related]
23. Comparison of surveillance and retroperitoneal lymph node dissection in Stage I nonseminomatous germ cell tumors.
Spermon JR; Roeleveld TA; van der Poel HG; Hulsbergen-van de Kaa CA; Ten Bokkel Huinink WW; van de Vijver M; Witjes JA; Horenblas S
Urology; 2002 Jun; 59(6):923-9. PubMed ID: 12031382
[TBL] [Abstract][Full Text] [Related]
24. Retroperitoneal recurrences after retroperitoneal lymph node dissection for low-stage nonseminomatous germ cell tumors.
Cespedes RD; Peretsman SJ
Urology; 1999 Sep; 54(3):548-52. PubMed ID: 10475370
[TBL] [Abstract][Full Text] [Related]
25. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
[TBL] [Abstract][Full Text] [Related]
26. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
[TBL] [Abstract][Full Text] [Related]
27. Percentage of Teratoma in Orchiectomy and Risk of Retroperitoneal Teratoma at the Time of Postchemotherapy Retroperitoneal Lymph Node Dissection in Germ Cell Tumors.
Calaway AC; Kern SQ; Crook D; Tong Y; Masterson TA; Adra N; Einhorn LH; Foster RS; Cary C
J Urol; 2021 Dec; 206(6):1430-1437. PubMed ID: 34288715
[TBL] [Abstract][Full Text] [Related]
28. Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion.
Stephenson AJ; Bosl GJ; Bajorin DF; Stasi J; Motzer RJ; Sheinfeld J
J Urol; 2005 Aug; 174(2):557-60; discussion 560. PubMed ID: 16006891
[TBL] [Abstract][Full Text] [Related]
29. The role of retroperitoneal lymph node dissection in the management of testicular cancer.
Stephenson AJ; Sheinfeld J
Urol Oncol; 2004; 22(3):225-33; discussion 234-5. PubMed ID: 15271322
[TBL] [Abstract][Full Text] [Related]
30. Primary vs. post-chemotherapy retroperitoneal lymph node dissection (RPLND) in patients with presence of teratoma at orchiectomy.
Williams SB; Kacker R; Steele GS; Richie JP
Urol Oncol; 2012; 30(1):60-3. PubMed ID: 20189842
[TBL] [Abstract][Full Text] [Related]
31. Primary Retroperitoneal Lymph Node Dissection for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary?
Tachibana I; Kern SQ; Douglawi A; Tong Y; Mahmoud M; Masterson TA; Adra N; Foster RS; Einhorn LH; Cary C
J Clin Oncol; 2022 Nov; 40(32):3762-3769. PubMed ID: 35675585
[TBL] [Abstract][Full Text] [Related]
32. Retroperitoneal imaging with third and fourth generation computed axial tomography in clinical stage I nonseminomatous germ cell tumors.
Fernandez EB; Moul JW; Foley JP; Colon E; McLeod DG
Urology; 1994 Oct; 44(4):548-52. PubMed ID: 7941194
[TBL] [Abstract][Full Text] [Related]
33. Results of retroperitoneal lymph node dissection for clinical stage I and II pure embryonal carcinoma of the testis.
Pohar KS; Rabbani F; Bosl GJ; Motzer RJ; Bajorin D; Sheinfeld J
J Urol; 2003 Oct; 170(4 Pt 1):1155-8. PubMed ID: 14501714
[TBL] [Abstract][Full Text] [Related]
34. A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only.
Nicolai N; Miceli R; Artusi R; Piva L; Pizzocaro G; Salvioni R
J Urol; 2004 Jan; 171(1):172-6. PubMed ID: 14665870
[TBL] [Abstract][Full Text] [Related]
35. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle: an update.
Yoon GH; Stein JP; Skinner DG
Urol Oncol; 2005; 23(3):168-77. PubMed ID: 15907716
[TBL] [Abstract][Full Text] [Related]
36. Surgical management of low-stage nonseminomatous germ cell testicular cancer.
Stephenson AJ; Klein EA
BJU Int; 2009 Nov; 104(9 Pt B):1362-8. PubMed ID: 19840014
[TBL] [Abstract][Full Text] [Related]
37. [Clinical stage I mature teratoma of the testis--retroperitoneal lymphadenectomy or surveillance?].
Heidenreich A; Neubauer S; Mostofi FK; Sesterhenn IA; Moul JW; Engelmann UH
Urologe A; 1997 Sep; 36(5):440-4. PubMed ID: 9424796
[TBL] [Abstract][Full Text] [Related]
38. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumor: a large single institution experience.
Hyams ES; Pierorazio P; Proteek O; Sroka M; Kavoussi LR; Allaf ME
J Urol; 2012 Feb; 187(2):487-92. PubMed ID: 22177913
[TBL] [Abstract][Full Text] [Related]
39. Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer.
Stephenson AJ; Bosl GJ; Motzer RJ; Bajorin DF; Stasi JP; Sheinfeld J
J Clin Oncol; 2007 Dec; 25(35):5597-602. PubMed ID: 18065732
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors in clinical stage I nonseminomatous germ cell testicular tumors: rationale for different risk-adapted treatment.
Ondrus D; Matoska J; Belan V; Kausitz J; Goncalves F; Hornák M
Eur Urol; 1998; 33(6):562-6. PubMed ID: 9743698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]